381 related articles for article (PubMed ID: 9819705)
21. Peroxisomes, Refsum's disease and the alpha- and omega-oxidation of phytanic acid.
Wanders RJ; Komen JC
Biochem Soc Trans; 2007 Nov; 35(Pt 5):865-9. PubMed ID: 17956234
[TBL] [Abstract][Full Text] [Related]
22. Biochemical abnormalities in rhizomelic chondrodysplasia punctata.
Hoefler G; Hoefler S; Watkins PA; Chen WW; Moser A; Baldwin V; McGillivary B; Charrow J; Friedman JM; Rutledge L
J Pediatr; 1988 May; 112(5):726-33. PubMed ID: 2452243
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis of peroxisomal disorders by analysis of phytanic and pristanic acids in stored blood spots collected at neonatal screening.
ten Brink HJ; van den Heuvel CM; Christensen E; Largillière C; Jakobs C
Clin Chem; 1993 Sep; 39(9):1904-6. PubMed ID: 8375069
[TBL] [Abstract][Full Text] [Related]
24. Detection of unusual very-long-chain fatty acid and ether lipid derivatives in the fibroblasts and plasma of patients with peroxisomal diseases using liquid chromatography-mass spectrometry.
Takashima S; Toyoshi K; Itoh T; Kajiwara N; Honda A; Ohba A; Takemoto S; Yoshida S; Shimozawa N
Mol Genet Metab; 2017 Mar; 120(3):255-268. PubMed ID: 28089346
[TBL] [Abstract][Full Text] [Related]
25. Pristanic acid beta-oxidation in peroxisomal disorders: studies in cultured human fibroblasts.
Verhoeven NM; Schor DS; Roe CR; Wanders RJ; Jakobs C
Biochim Biophys Acta; 1998 Apr; 1391(3):351-6. PubMed ID: 9555092
[TBL] [Abstract][Full Text] [Related]
26. Phytanic acid: production from phytol, its breakdown and role in human disease.
van den Brink DM; Wanders RJ
Cell Mol Life Sci; 2006 Aug; 63(15):1752-65. PubMed ID: 16799769
[TBL] [Abstract][Full Text] [Related]
27. Biochemical markers predicting survival in peroxisome biogenesis disorders.
Gootjes J; Mooijer PA; Dekker C; Barth PG; Poll-The BT; Waterham HR; Wanders RJ
Neurology; 2002 Dec; 59(11):1746-9. PubMed ID: 12473763
[TBL] [Abstract][Full Text] [Related]
28. Phytanic acid alpha-oxidation in rat liver peroxisomes. Production of alpha-hydroxyphytanoyl-CoA and formate is enhanced by dioxygenase cofactors.
Mihalik SJ; Rainville AM; Watkins PA
Eur J Biochem; 1995 Sep; 232(2):545-51. PubMed ID: 7556205
[TBL] [Abstract][Full Text] [Related]
29. Pristanic acid and phytanic acid in plasma from patients with peroxisomal disorders: stable isotope dilution analysis with electron capture negative ion mass fragmentography.
ten Brink HJ; Stellaard F; van den Heuvel CM; Kok RM; Schor DS; Wanders RJ; Jakobs C
J Lipid Res; 1992 Jan; 33(1):41-7. PubMed ID: 1372637
[TBL] [Abstract][Full Text] [Related]
30. The chemical biology of branched-chain lipid metabolism.
Mukherji M; Schofield CJ; Wierzbicki AS; Jansen GA; Wanders RJ; Lloyd MD
Prog Lipid Res; 2003 Sep; 42(5):359-76. PubMed ID: 12814641
[TBL] [Abstract][Full Text] [Related]
31. Quantification of Very-Long-Chain and Branched-Chain Fatty Acids in Plasma by Liquid Chromatography-Tandem Mass Spectrometry.
De Biase I; Pasquali M
Methods Mol Biol; 2022; 2546():509-521. PubMed ID: 36127618
[TBL] [Abstract][Full Text] [Related]
32. Fibroblast studies documenting a case of peroxisomal 2-methylacyl-CoA racemase deficiency: possible link between racemase deficiency and malabsorption and vitamin K deficiency.
Van Veldhoven PP; Meyhi E; Squires RH; Fransen M; Fournier B; Brys V; Bennett MJ; Mannaerts GP
Eur J Clin Invest; 2001 Aug; 31(8):714-22. PubMed ID: 11473573
[TBL] [Abstract][Full Text] [Related]
33. Identification of pristanal dehydrogenase activity in peroxisomes: conclusive evidence that the complete phytanic acid alpha-oxidation pathway is localized in peroxisomes.
Jansen GA; van den Brink DM; Ofman R; Draghici O; Dacremont G; Wanders RJ
Biochem Biophys Res Commun; 2001 May; 283(3):674-9. PubMed ID: 11341778
[TBL] [Abstract][Full Text] [Related]
34. Phytanic acid and pristanic acid, branched-chain fatty acids associated with Refsum disease and other inherited peroxisomal disorders, mediate intracellular Ca2+ signaling through activation of free fatty acid receptor GPR40.
Kruska N; Reiser G
Neurobiol Dis; 2011 Aug; 43(2):465-72. PubMed ID: 21570468
[TBL] [Abstract][Full Text] [Related]
35. Hyperpipecolic acidaemia: a diagnostic tool for peroxisomal disorders.
Peduto A; Baumgartner MR; Verhoeven NM; Rabier D; Spada M; Nassogne MC; Poll-The BT; Bonetti G; Jakobs C; Saudubray JM
Mol Genet Metab; 2004 Jul; 82(3):224-30. PubMed ID: 15234336
[TBL] [Abstract][Full Text] [Related]
36. New insights in peroxisomal beta-oxidation. Implications for human peroxisomal disorders.
Van Veldhoven PP
Verh K Acad Geneeskd Belg; 1998; 60(3):195-214. PubMed ID: 9803880
[TBL] [Abstract][Full Text] [Related]
37. A comparative study of straight chain and branched chain fatty acid oxidation in skin fibroblasts from patients with peroxisomal disorders.
Singh H; Usher S; Johnson D; Poulos A
J Lipid Res; 1990 Feb; 31(2):217-25. PubMed ID: 1691260
[TBL] [Abstract][Full Text] [Related]
38. Peroxisomal disorders affecting phytanic acid alpha-oxidation: a review.
Wierzbicki AS
Biochem Soc Trans; 2007 Nov; 35(Pt 5):881-6. PubMed ID: 17956237
[TBL] [Abstract][Full Text] [Related]
39. Pseudo infantile Refsum's disease: catalase-deficient peroxisomal particles with partial deficiency of plasmalogen synthesis and oxidation of fatty acids.
Aubourg P; Kremser K; Roland MO; Rocchiccioli F; Singh I
Pediatr Res; 1993 Sep; 34(3):270-6. PubMed ID: 7510868
[TBL] [Abstract][Full Text] [Related]
40. Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism.
Van Veldhoven PP
J Lipid Res; 2010 Oct; 51(10):2863-95. PubMed ID: 20558530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
